• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis.加替沙星滴眼液治疗细菌性结膜炎的临床应用
Clin Ophthalmol. 2011;5:495-502. doi: 10.2147/OPTH.S13778. Epub 2011 Apr 18.
2
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.0.6%贝西沙星眼用混悬液与0.3%加替沙星滴眼液治疗新生儿细菌性结膜炎的比较
Drugs R D. 2017 Mar;17(1):167-175. doi: 10.1007/s40268-016-0164-6.
3
The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.莫西沙星滴眼液在治疗细菌性结膜炎中的作用。
Clin Drug Investig. 2011;31(8):543-557. doi: 10.2165/11589020-000000000-00000.
4
A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis.一项随机、研究者设盲的临床试验,比较0.3%加替沙星每日两次给药与每日四次给药治疗急性细菌性结膜炎的疗效和安全性。
Curr Med Res Opin. 2005 Mar;21(3):425-31. doi: 10.1185/030079905X30699.
5
The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.在新西兰白兔模型中使用Zymar(加替沙星0.3%)成功治疗耐加替沙星金黄色葡萄球菌性角膜炎。
Am J Ophthalmol. 2005 May;139(5):867-77. doi: 10.1016/j.ajo.2005.01.021.
6
Gatifloxacin 0.5% administered twice daily for the treatment of acute bacterial conjunctivitis in patients one year of age or older.0.5%加替沙星每日给药两次,用于治疗一岁及以上患者的急性细菌性结膜炎。
J Ocul Pharmacol Ther. 2014 Dec;30(10):815-22. doi: 10.1089/jop.2014.0040.
7
Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.贝西沙星滴眼液 0.6%,每日 2 次,连续 3 天治疗细菌性结膜炎的疗效和耐受性:成人和儿童多中心、随机、双盲、对照、平行组研究。
Clin Ther. 2011 Jan;33(1):13-26. doi: 10.1016/j.clinthera.2010.12.004.
8
[Comparative research of the efficacy of the gatifloxacin and levofloxacin for bacterial conjunctivitis in human eyes].加替沙星与左氧氟沙星治疗人眼细菌性结膜炎疗效的对比研究
Zhonghua Yan Ke Za Zhi. 2010 Jun;46(6):525-31.
9
Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.过去十年间,纽约眼耳医院常见细菌性结膜炎分离株体外抗生素药敏性的变化趋势。
Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):111-9. doi: 10.1007/s00417-010-1426-6. Epub 2010 Jun 8.
10
Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.0.6%帕珠沙星滴眼液与莫西沙星 0.5%和加替沙星 0.5%治疗细菌性结膜炎的疗效和安全性:一项随机临床试验。
J Ocul Pharmacol Ther. 2018 Apr;34(3):250-255. doi: 10.1089/jop.2017.0056. Epub 2018 Jan 11.

引用本文的文献

1
Enhanced Detection of Bacterial Ocular Pathogens: A Comparative Study of Broad-Range Real-Time PCR and Conventional Culture Methods.细菌眼部病原体的增强检测:宽范围实时聚合酶链反应与传统培养方法的比较研究
Diagnostics (Basel). 2025 Apr 10;15(8):966. doi: 10.3390/diagnostics15080966.
2
Micellar HPLC and UV Methods with Time Programming for Synchronically Quantifying Gatifloxacin and Its Preservative in Eye Drops: Appraisal of Ecological Impact.采用时间程序的胶束高效液相色谱法和紫外法同步定量滴眼液中加替沙星及其防腐剂:生态影响评估
ACS Omega. 2025 Feb 20;10(8):8472-8483. doi: 10.1021/acsomega.4c10508. eCollection 2025 Mar 4.
3
Gatifloxacin hydrochloride confers broad-spectrum antibacterial activity against phytopathogenic bacteria.盐酸加替沙星对植物病原菌具有广谱抗菌活性。
Front Microbiol. 2024 Dec 2;15:1504243. doi: 10.3389/fmicb.2024.1504243. eCollection 2024.
4
Targeted Bacterial Keratitis Treatment with Polyethylene Glycol-Dithiothreitol-Boric Acid Hydrogel and Gatifloxacin.聚乙二醇-二硫苏糖醇-硼酸水凝胶联合加替沙星靶向治疗细菌性角膜炎。
Curr Drug Deliv. 2024;21(11):1548-1558. doi: 10.2174/0115672018279105240226050253.
5
Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?氟喹诺酮类抗菌药物的副作用概述:新药与旧药对比,安全性方面是否有所进步?
Pharmaceutics. 2023 Mar 1;15(3):804. doi: 10.3390/pharmaceutics15030804.
6
A Case-Control Study to Determine the Microbiological Spectrum and Antibiotic Sensitivity Patterns in Congenital Nasolacrimal Duct Obstruction.一项确定先天性鼻泪管阻塞微生物谱及抗生素敏感性模式的病例对照研究。
J Curr Ophthalmol. 2022 Jul 26;34(2):251-256. doi: 10.4103/joco.joco_216_21. eCollection 2022 Apr-Jun.
7
Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance.氟喹诺酮类杂化分子作为对抗抗菌耐药性的有前景的抗菌剂。
Pharmaceutics. 2022 Aug 22;14(8):1749. doi: 10.3390/pharmaceutics14081749.
8
Piperazine based antimicrobial polymers: a review.基于哌嗪的抗菌聚合物:综述
RSC Adv. 2021 Apr 23;11(25):15213-15230. doi: 10.1039/d1ra00341k. eCollection 2021 Apr 21.
9
Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones-Shaping the Fifth Generation.千禧一代抗菌(氟)喹诺酮类药物的结构表征——塑造第五代产品
Pharmaceutics. 2021 Aug 18;13(8):1289. doi: 10.3390/pharmaceutics13081289.
10
Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts.评估加替沙星、左氧氟沙星和庆大霉素对棘阿米巴包囊的体外疗效。
Int Ophthalmol. 2020 Feb;40(2):361-368. doi: 10.1007/s10792-019-01188-4. Epub 2019 Oct 5.

本文引用的文献

1
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.眼感染中新兴的抗生素耐药性和氟喹诺酮类药物的作用。
J Cataract Refract Surg. 2010 Sep;36(9):1588-98. doi: 10.1016/j.jcrs.2010.06.028.
2
Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.过去十年间,纽约眼耳医院常见细菌性结膜炎分离株体外抗生素药敏性的变化趋势。
Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):111-9. doi: 10.1007/s00417-010-1426-6. Epub 2010 Jun 8.
3
Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration.局部眼部给药后人体结膜中贝西沙星、加替沙星和莫西沙星的浓度。
Clin Ophthalmol. 2010 Apr 26;4:331-41. doi: 10.2147/opth.s9163.
4
Hospital-acquired conjunctivitis in a neonatal intensive care unit: Bacterial etiology and susceptibility patterns.新生儿重症监护病房获得性结膜炎:细菌病因和药敏模式。
Am J Infect Control. 2010 Oct;38(8):650-2. doi: 10.1016/j.ajic.2010.01.002. Epub 2010 Apr 13.
5
Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin.依次滴用的局部用莫西沙星、加替沙星和左氧氟沙星的眼内穿透性。
Clin Ophthalmol. 2009;3:553-7. doi: 10.2147/opth.s7757. Epub 2009 Oct 19.
6
Kill rates of preserved and preservative-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus.含防腐剂和不含防腐剂的外用8-甲氧基氟喹诺酮对各种葡萄球菌菌株的杀灭率。
J Cataract Refract Surg. 2009 Sep;35(9):1609-13. doi: 10.1016/j.jcrs.2009.04.036.
7
Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.盐酸莫西沙星滴眼液治疗细菌性眼部感染的综述
Clin Ophthalmol. 2008 Mar;2(1):77-91. doi: 10.2147/opth.s1666.
8
Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.苯扎氯铵增强了加替沙星的抗菌活性,并降低了其选择氟喹诺酮耐药菌株的倾向。
J Ocul Pharmacol Ther. 2009 Aug;25(4):329-34. doi: 10.1089/jop.2009.0031.
9
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.第四代氟喹诺酮类眼科制剂的细菌清除率。
Adv Ther. 2009 Apr;26(4):447-54. doi: 10.1007/s12325-009-0018-5. Epub 2009 Apr 16.
10
A comparison of fluoroquinolone penetration into human conjunctival tissue.氟喹诺酮类药物在人结膜组织中渗透性的比较。
J Ocul Pharmacol Ther. 2008 Dec;24(6):587-91. doi: 10.1089/jop.2008.0055.

加替沙星滴眼液治疗细菌性结膜炎的临床应用

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis.

作者信息

Cervantes Lorenzo J, Mah Francis S

机构信息

Department of Ophthalmology, Cornea and External Disease, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

出版信息

Clin Ophthalmol. 2011;5:495-502. doi: 10.2147/OPTH.S13778. Epub 2011 Apr 18.

DOI:10.2147/OPTH.S13778
PMID:21573098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3090305/
Abstract

Bacterial conjunctivitis is a common infectious disease of the eye, characterized by conjunctival hyperemia, eyelid edema, and purulent discharge. Although the prevalence and incidence are not well reported, bacterial conjunctivitis represents one of the most frequent causes of patient visits to both primary care physicians and ophthalmologists. Most cases of nongonococcal and nonchlamydial bacterial conjunctivitis are self-limiting and may resolve without intervention. There is a place for treatment, however, which allows for a shorter time to clinical and microbiological resolution which may decrease the mild morbidity, decrease health care costs of visits and potential complications, return patients back to school or the work force, and limit the potential spread of this communicable infection. Gatifloxacin ophthalmic solution is a broad spectrum 8-methoxyfluroroquinolone bactericidal antibiotic, with good activity against Staphylococcus aureus, Streptococcus species, and Gram-negative pathogens. It also has a relatively good resistance profile, making it a more than adequate choice in the treatment of bacterial conjunctivitis when therapy is warranted.

摘要

细菌性结膜炎是一种常见的眼部传染病,其特征为结膜充血、眼睑水肿和脓性分泌物。尽管患病率和发病率的报道并不充分,但细菌性结膜炎是患者就诊于初级保健医生和眼科医生的最常见原因之一。大多数非淋菌性和非衣原体性细菌性结膜炎病例是自限性的,可能无需干预即可痊愈。然而,治疗仍有其意义,它可以缩短临床和微生物学治愈时间,可能降低轻微发病率,降低就诊的医疗费用和潜在并发症,使患者重返学校或工作岗位,并限制这种传染病的潜在传播。加替沙星滴眼液是一种广谱8-甲氧基氟喹诺酮类杀菌抗生素,对金黄色葡萄球菌、链球菌属和革兰氏阴性病原体具有良好活性。它还具有相对较好的耐药性,在有必要进行治疗时,是治疗细菌性结膜炎的一个足够好的选择。